Marjorie A. Shapiro, PhD FDA

Dr. Marjorie Shapiro received her Ph.D. in immunology from the University of Pennsylvania where she studied molecular mechanisms underlying antibody diversity. She joined the Division of Monoclonal Antibodies/FDA in 1993 and is currently a Lab Chief in the Division of Biotechnology Review and Research 1, Office of Biotechnology Products. She is known for her expertise in therapeutic monoclonal antibodies and related products such as antibody-drug conjugates, bispecific antibodies, antibody cocktails, Fc-fusion proteins, as well as biosimilars.